350
article
Milken Institute Launches “Early Warning” Initiative for Emerging Pandemic Threats as COVID-19 Cases Increase
Washington, D.C. – Dec.
video
Part 1: A Conversation with Rep. Anna Eshoo | Part 2: Unseen Burdens: Managing Chronic Disease During COVID-19 and Beyond
June 23 at 9:00 am PDT / 12:00 pm EDT
This session will begin with a conversation wi
th Anna Eshoo, Chair of the Energy and Commerce Subcommittee on Health, US House of Representatives, followed by a panel discussion.
+ Read More
article
BioBank Central Launches Online Forum to Drive Global Connectivity Among Biobanking Community
Washington, D.C., May 30, 2007 — BioBank Central, a web-based portal that provides information and
news about the importance of biospecimens to research, announced today the launch of its BioBank Forum, an online forum to frame the debate and en
+ Read More
article
TRAIN Newsletter — September 2022
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically
article
Does it Work for Patients? A Multi-Step Approach to Defining Performance and Measuring Progress Across the Biomedical Ecosystem
Quick Links
Step One: Discover Existing Research »
Step Two: Articulate Ideals»
Step Three: Ident
ify Measures »
+ Read More
article
Medicare Drug Price Negotiation Program Comment Letter
Meena Seshamani, M.D., Ph.D.
Deputy Administrator and Director of the Center for Medicare
Centers fo
r Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, Maryland 21244
Dear Dr. Seshamani,
+ Read More
article
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies
Introduction
Advances in cell and gene therapies are transforming how we treat or potentially cure
disease. Cell and gene therapies aim to address the underlying cause of genetic and acquired diseases.
+ Read More
article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth
Associate Commissioner for Policy
Food and Drug Administration
5630 Fishers Lane, Rm.
1061
Rockville, MD 20852
Dear Ms. Roth,
+ Read More
article
Cures for Life Quarterly
In this Cures for Life Issue
Featured Story
Regulatory
Coverage and Reimbursement
Policy
FasterCure
s’ Resources
+ Read More
article
Stories from the Front Lines of Advancing Therapeutic Development for Patients: The Research Acceleration and Innovation Network Enters a New Decade
.bubble-images, .bubble-images img {
border-radius: 50%;
}
Stories from the Front Lines of Advanci
ng Therapeutic Development for Patients: The Research Acceleration and Innovation Network Enters a New Decade
M
+ Read More
article
Congress Passes 21st Century Cures Act, Bringing Forth New Era for Biomedical Innovation
WASHINGTON, DC — FasterCures, a center of the Milken Institute, commends the U.S. Senate on today’s
strong, bipartisan support of the 21st Century Cures Act (H.R.
+ Read More